Lateral flow immunoassay (LFIA) with gold nanoparticles (AuNPs) as signal reporters is a
popular point-of-care diagnostic technique. However, given the weak absorbance of …

Background: Traditional lateral flow immunoassay (LFIA) based on 20-40 nm gold
nanoparticles (AuNPs) as signal reporter always suffers from relatively low detection …

The lateral flow immunoassay (LFIA) strip has been one of the classic but dominant tools in
the point of care (POC) field with the advantages of portability and simplicity. As the signal …

Achieving metal nanoparticles with high peroxidase activity and visible-light plasmonic
property for lateral flow immunoassay has attracted extensive attention in the industry …

Lateral flow immunoassay (LFIA) has played a vital role in point-of-care (POC) testing on
account of its simplicity, rapidity, and low cost. However, the low sensitivity and difficulty of …

Au nanoparticles (AuNPs) as signal reporters have been utilized in colorimetric in vitro
diagnostics (IVDs) for decades. Nevertheless, it remains a grand challenge to substantially …

As a representative technology for point‐of‐care testing (POCT), lateral flow immunoassay
(LFIA) has been broadly used to detect analytes in many fields. However, its clinical …

Lateral flow immunoassays (LFIAs) have been developed rapidly in recent years and used
in a wide range of application at point-of-care-testing (POCT), where small biomolecules can …

The colorimetric lateral flow assay (CLFA, also known as test strip) is a widely used point-of-
care diagnostic technology. It has been a challenge to significantly improve the detection …

Lateral flow immunoassay (LFIA) is a rapid and simple point-of-care method for the detection
of various analytes. In the colorimetric sandwich format, the reaction outcome is a colored …